Logo image of GRA.CA

NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis

Canada - TSX:GRA - CA63010G1000 - Common Stock

2.85 CAD
-0.03 (-1.04%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, GRA scores 3 out of 10 in our fundamental rating. GRA was compared to 30 industry peers in the Chemicals industry. GRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, GRA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GRA had negative earnings in the past year.
GRA had a positive operating cash flow in the past year.
In the past 5 years GRA always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: GRA reported negative operating cash flow in multiple years.
GRA.CA Yearly Net Income VS EBIT VS OCF VS FCFGRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.48%, GRA is in line with its industry, outperforming 53.33% of the companies in the same industry.
GRA has a Return On Equity of -9.69%. This is comparable to the rest of the industry: GRA outperforms 53.33% of its industry peers.
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRA.CA Yearly ROA, ROE, ROICGRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

GRA has a Gross Margin (18.57%) which is comparable to the rest of the industry.
GRA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
GRA.CA Yearly Profit, Operating, Gross MarginsGRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRA has more shares outstanding than it did 5 years ago.
GRA.CA Yearly Shares OutstandingGRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M
GRA.CA Yearly Total Debt VS Total AssetsGRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 6.13 indicates that GRA is not in any danger for bankruptcy at the moment.
GRA's Altman-Z score of 6.13 is amongst the best of the industry. GRA outperforms 83.33% of its industry peers.
GRA has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, GRA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 6.13
ROIC/WACCN/A
WACC8.27%
GRA.CA Yearly LT Debt VS Equity VS FCFGRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.99 indicates that GRA should not have too much problems paying its short term obligations.
The Current ratio of GRA (1.99) is comparable to the rest of the industry.
GRA has a Quick Ratio of 1.44. This is a normal value and indicates that GRA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GRA (1.44) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.44
GRA.CA Yearly Current Assets VS Current LiabilitesGRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GRA have decreased by 0.00% in the last year.
GRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.12%.
GRA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.33% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%

3.2 Future

Based on estimates for the next years, GRA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.61% on average per year.
Based on estimates for the next years, GRA will show a quite strong growth in Revenue. The Revenue will grow by 17.90% on average per year.
EPS Next Y13.02%
EPS Next 2Y17.59%
EPS Next 3Y29.43%
EPS Next 5Y29.61%
Revenue Next Year0.4%
Revenue Next 2Y7.74%
Revenue Next 3Y22.12%
Revenue Next 5Y17.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GRA.CA Yearly Revenue VS EstimatesGRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M
GRA.CA Yearly EPS VS EstimatesGRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.05 -0.05 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRA.CA Price Earnings VS Forward Price EarningsGRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

GRA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 123.11
GRA.CA Per share dataGRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as GRA's earnings are expected to grow with 29.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.59%
EPS Next 3Y29.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANOXPLORE INC

TSX:GRA (9/26/2025, 7:00:00 PM)

2.85

-0.03 (-1.04%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-16 2025-09-16/amc
Earnings (Next)11-04 2025-11-04
Inst Owners12.56%
Inst Owner ChangeN/A
Ins Owners7.38%
Ins Owner ChangeN/A
Market Cap486.24M
Analysts76
Price Target3.83 (34.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.99%
Min EPS beat(2)-53.98%
Max EPS beat(2)33.99%
EPS beat(4)2
Avg EPS beat(4)-8.63%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)6
Avg EPS beat(12)-31.39%
EPS beat(16)7
Avg EPS beat(16)-61.64%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-14.65%
Max Revenue beat(2)-5.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-5.88%
Revenue beat(12)4
Avg Revenue beat(12)-2.77%
Revenue beat(16)5
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.59
P/FCF N/A
P/OCF 111.03
P/B 4.82
P/tB 5.59
EV/EBITDA 123.11
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.03
OCFY0.9%
SpS0.79
BVpS0.59
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.57%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 3.63
Cap/Depr 108.56%
Cap/Sales 8.99%
Interest Coverage N/A
Cash Conversion 109.67%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.44
Altman-Z 6.13
F-Score5
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)78.57%
Cap/Depr(5y)156.07%
Cap/Sales(3y)6.19%
Cap/Sales(5y)12.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y13.02%
EPS Next 2Y17.59%
EPS Next 3Y29.43%
EPS Next 5Y29.61%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%
Revenue Next Year0.4%
Revenue Next 2Y7.74%
Revenue Next 3Y22.12%
Revenue Next 5Y17.9%
EBIT growth 1Y44.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.09%
EBIT Next 3Y68.1%
EBIT Next 5Y64.1%
FCF growth 1Y23.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y248.81%
OCF growth 3YN/A
OCF growth 5YN/A